Subject(s)
Civil Rights/legislation & jurisprudence , Health Policy/legislation & jurisprudence , Public Health/legislation & jurisprudence , COVID-19/prevention & control , Constitution and Bylaws , Federal Government , Humans , Mandatory Programs/legislation & jurisprudence , State Government , United StatesSubject(s)
COVID-19 Vaccines , COVID-19 , Commerce/legislation & jurisprudence , Health Personnel/legislation & jurisprudence , Mandatory Programs/legislation & jurisprudence , Public Health/legislation & jurisprudence , Supreme Court Decisions , United States Occupational Safety and Health Administration/legislation & jurisprudence , COVID-19/diagnosis , Humans , Mandatory Programs/trends , Mandatory Testing/legislation & jurisprudence , United StatesSubject(s)
COVID-19 Vaccines , COVID-19 , Commerce/legislation & jurisprudence , Mandatory Programs/legislation & jurisprudence , Supreme Court Decisions , United States Occupational Safety and Health Administration/legislation & jurisprudence , COVID-19/diagnosis , Forecasting , Humans , Mandatory Testing/legislation & jurisprudence , United StatesSubject(s)
COVID-19/transmission , Cross Infection/prevention & control , Disease Transmission, Infectious/prevention & control , SARS-CoV-2 , COVID-19/epidemiology , COVID-19 Vaccines , Cross Infection/epidemiology , Government Regulation , Health Personnel , Hospitals , Humans , Immunization, Secondary , Infectious Disease Transmission, Professional-to-Patient/prevention & control , Mandatory Programs/legislation & jurisprudence , SARS-CoV-2/pathogenicity , United StatesSubject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Mandatory Programs/legislation & jurisprudence , State Medicine/legislation & jurisprudence , Vaccination/legislation & jurisprudence , COVID-19/economics , COVID-19/epidemiology , COVID-19 Vaccines/economics , England/epidemiology , Government Employees/legislation & jurisprudence , Health Policy/economics , Health Policy/legislation & jurisprudence , Humans , Mandatory Programs/economics , Mandatory Programs/standards , State Medicine/standards , Vaccination/economics , Vaccination/standardsSubject(s)
COVID-19/prevention & control , Health Personnel/legislation & jurisprudence , Mandatory Programs/legislation & jurisprudence , State Medicine/legislation & jurisprudence , Vaccination/legislation & jurisprudence , Attitude of Health Personnel , COVID-19/epidemiology , COVID-19/virology , England/epidemiology , Health Personnel/standards , Humans , Immunization, Secondary/standards , Infectious Disease Transmission, Professional-to-Patient/prevention & control , Mandatory Programs/standards , Pandemics/prevention & control , SARS-CoV-2/pathogenicity , State Medicine/standards , Vaccination/standardsSubject(s)
COVID-19/prevention & control , Communicable Disease Control/legislation & jurisprudence , Mandatory Programs/legislation & jurisprudence , Private Sector/legislation & jurisprudence , Public Health/legislation & jurisprudence , Quarantine/legislation & jurisprudence , Vaccination/legislation & jurisprudence , COVID-19/transmission , COVID-19 Vaccines , Centers for Disease Control and Prevention, U.S./legislation & jurisprudence , Civil Rights/legislation & jurisprudence , Federal Government , Health Education , Humans , Occupational Health/legislation & jurisprudence , Religion , State Government , United StatesABSTRACT
Vaccine safety is their main concern.
Subject(s)
COVID-19 Vaccines , COVID-19/prevention & control , Nurses/psychology , Patient Acceptance of Health Care , Humans , Mandatory Programs/legislation & jurisprudence , Nurses/legislation & jurisprudence , United States , Vaccination/legislation & jurisprudenceSubject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Mandatory Programs/legislation & jurisprudence , Public Policy/legislation & jurisprudence , Vaccination/legislation & jurisprudence , Allergy and Immunology , Australia/epidemiology , COVID-19/epidemiology , COVID-19 Vaccines/standards , Humans , Intersectoral Collaboration , Pandemics/prevention & control , Social Sciences , Vaccination/standardsABSTRACT
Behavioral epidemiology suggests that there is a tight dynamic coupling between the timeline of an epidemic outbreak, and the social response in the affected population (with a typical course involving physical distancing between individuals, avoidance of large gatherings, wearing masks, etc). We study the bidirectional coupling between the epidemic dynamics of COVID-19 and the population social response in the state of New York, between March 1, 2020 (which marks the first confirmed positive diagnosis in the state), until June 20, 2020. This window captures the first state-wide epidemic wave, which peaked to over 11,000 confirmed cases daily in April (making New York one of the US states most severely affected by this first wave), and subsided by the start of June to a count of consistently under 1,500 confirmed cases per day (suggesting temporary state-wide control of the epidemic). In response to the surge in cases, social distancing measures were gradually introduced over two weeks in March, culminating with the PAUSE directive on March 22nd, which mandated statewide shutdown of all nonessential activity. The mandates were then gradually relaxed in stages throughout summer, based on how epidemic benchmarks were met in various New York regions. In our study, we aim to examine on one hand, whether different counties exhibited different responses to the PAUSE centralized measures depending on their epidemic situation immediately preceding PAUSE. On the other hand, we explore whether these different county-wide responses may have contributed in turn to modulating the counties' epidemic timelines. We used the public domain to extract county-wise epidemic measures (such as cumulative and daily incidence of COVID-19), and social mobility measures for different modalities (driving, walking, public transit) and to different destinations. Our correlation analyses between the epidemic and the mobility time series found significant correlations between the size of the epidemic and the degree of mobility drop after PAUSE, as well as between the mobility comeback patterns and the epidemic recovery timeline. In line with existing literature on the role of the population behavioral response during an epidemic outbreak, our results support the potential importance of the PAUSE measures to the control of the first epidemic wave in New York State.